V028-7671 Screening compound: 1-{8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-C]QUINAZOLIN-5-YL}-4-METHYLPIPERIDINE

V028-7671 Screening compound: 1-{8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-C]QUINAZOLIN-5-YL}-4-METHYLPIPERIDINE
V028-7671 Screening compound: 1-{8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-C]QUINAZOLIN-5-YL}-4-METHYLPIPERIDINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-7671
1-{8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-C]QUINAZOLIN-5-YL}-4-METHYLPIPERIDINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-7671

Molecular Formula

C18H20ClN5 (C18 H20 ClN5)

Compound Name

1-{8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-C]QUINAZOLIN-5-YL}-4-METHYLPIPERIDINE

IUPAC name

n/a

SMILES

CC(CC1)CCN1c1nc(cc(cc2)Cl)c2c2nnc(C3CC3)n12

InChI

InChI=1S/C18H20ClN5/c1-11-6-8-23(9-7-11)18-20-15-10-13(19)4-5-14(15)17-22-21-16(24(17)18)12-2-3-12/h4-5,10-12H,2-3,6-9H2,1H3

InChI Key

YECGIGMOVZHHBH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922760

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

341.84

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.762

Distribution Coefficient, logD

4.761

Water Solubility, LogSw

-4.82

Polar Surface Area

33.516

Acid Dissociation Constant (pKa)

20.16

Base Dissociation Constant (pKb)

4.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

V028-7671 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

GPCR Targeted Library (31838 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V028-7671 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-7671?
Check Price and Availability of V028-7671, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-7671 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-7671
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-7671
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-7671 available by request